GI Innovation Inc. Logo

GI Innovation Inc.

Develops fusion protein biologics for oncology, allergic, and metabolic diseases.

358570 | KO

Overview

Corporate Details

ISIN(s):
KR7358570000
LEI:
Country:
South Korea
Address:
서울특별시 송파구 송파대로 167, 서울특별시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

GI Innovation Inc. is a biopharmaceutical company engaged in the research and development of next-generation immunotherapies. The company utilizes its proprietary GI-SMART™ platform to create innovative fusion protein-based biologics. Its development pipeline targets diseases with high unmet medical needs, focusing on therapeutic areas such as immuno-oncology (GI-101, GI-10N), allergic and fibrotic diseases (GI-301, GI-30N), and metabolic diseases (GI-20N). Operating under a "Science, Strategy, Speed" philosophy, GI Innovation advances its drug candidates through well-structured translational research and strategic collaborations with global pharmaceutical companies.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-12 00:00
Regulatory News Service
투자판단관련주요경영사항(임상시험계획승인신청) (건강한 성인 및 암 생존자를 대상으로 한 GI102 요법의 노화 관련 생…
Korean 8.2 KB
2025-09-05 00:00
Legal Proceedings Report
투자판단관련주요경영사항(임상시험계획변경승인신청) (GI101 단일 요법 또는 펨브롤리주맙 또는 렌바티닙 병용 요법의 안…
Korean 13.0 KB
2025-09-04 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.3 KB
2025-09-04 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.2 KB
2025-09-04 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.5 KB
2025-09-04 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 957.2 KB
2025-08-29 00:00
Share Issue/Capital Change
전환주식의전환청구권행사 (전환우선주)
Korean 15.3 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.2 MB
2025-08-05 00:00
Share Issue/Capital Change
주요사항보고서(전환사채매수선택권행사자지정)
Korean 23.8 KB
2025-07-10 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.3 KB
2025-07-02 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.5 KB
2025-06-30 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.2 KB
2025-06-26 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 604.9 KB
2025-06-04 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.2 KB
2025-06-04 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.4 KB

Automate Your Workflow. Get a real-time feed of all GI Innovation Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for GI Innovation Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for GI Innovation Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Shedir Pharma Group Logo
Develops and sells pharmaceutical, nutraceutical, and dermo-cosmetic products in Italy & Spain.
Italy
SHE
SHIELD THERAPEUTICS PLC Logo
Commercializing a novel oral therapy for adults with iron deficiency.
United Kingdom
STX
SHINPOONG PHARMACEUTICAL CO.,LTD Logo
R&D-driven pharma firm making APIs, finished drugs, and medical products for global markets.
South Korea
019170
Shionogi & Co.,Ltd. Logo
A research-driven pharmaceutical firm creating drugs, diagnostics, and devices for global health.
Japan
4507
Shuttle Pharmaceuticals Holdings, Inc. Logo
Develops drugs to enhance radiation therapy for cancer and offers predictive diagnostics.
United States of America
SHPH
Siegfried Holding AG Logo
Global CDMO providing development and manufacturing of APIs and finished drugs for the pharma industry.
Switzerland
SFZN
SIGA TECHNOLOGIES INC Logo
Develops antiviral drugs for global health security against biothreats and infectious diseases.
United States of America
SIGA
Silexion Therapeutics Corp Logo
Developing a local drug delivery platform to treat KRAS-driven cancers and solid tumors.
United States of America
SLXN
Develops oncolytic viruses and immunotherapeutics to destroy difficult-to-treat cancer cells.
South Korea
215600
Silo Pharma, Inc. Logo
Develops novel psychedelic & traditional therapies for pain and central nervous system disorders.
United States of America
SILO

Talk to a Data Expert

Have a question? We'll get back to you promptly.